Denali Therapeutics Ownership | Who Owns Denali Therapeutics?

Denali Therapeutics Ownership Summary

Denali Therapeutics is owned by 69.52% institutional investors, 9.13% insiders, and 21.35% retail investors. Blackrock is the largest institutional shareholder, holding 8.82% of DNLI shares. Scottish Mortgage Ord is the top mutual fund, with 4.44% of its assets in Denali Therapeutics shares.

DNLI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Denali Therapeutics	69.52%	9.13%	21.35%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	13.17M	8.82%	$305.91M
Vanguard group	13.06M	7.57%	$215.59M
Blackrock funding, inc. /de	13.03M	7.43%	$250.26M
Baillie gifford	12.07M	6.88%	$231.68M
T. rowe price investment management	8.52M	4.86%	$163.57M
Temasek (private)	7.01M	4.00%	$134.65M
State street	6.27M	3.57%	$120.42M
Norges bank	5.12M	2.97%	$84.52M
Fmr	4.58M	2.61%	$87.85M
Ubs asset management americas	4.43M	2.53%	$85.10M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Crestline management, lp	2.21M	91.74%	$42.45M
Lynx1 capital management lp	1.88M	5.71%	$36.10M
Foresite capital management vi	1.21M	5.05%	$23.23M
Casdin capital	1.84M	2.68%	$35.33M
Stempoint capital lp	426.56K	1.59%	$8.19M
Dafna capital management	318.50K	1.39%	$6.12M
Boxer capital management	250.00K	1.16%	$3.63M
Privium fund management b.v.	254.86K	1.02%	$4.89M
Yiheng capital management	469.98K	1.01%	$6.82M
Vestal point capital, lp	1.77M	0.95%	$34.05M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	5.12M	0.01%	5.12M
Vestal point capital, lp	1.77M	0.95%	1.31M
T. rowe price investment management	8.52M	0.11%	1.27M
Pictet asset management sa	2.56M	0.05%	1.23M
Artisan partners limited partnership	1.10M	0.03%	1.10M

Top Sellers

Holder	Shares	% Assets	Change
Point72 asset management	-	-	-1.70M
Fmr	4.58M	0.00%	-1.52M
Price t rowe associates inc /md/	2.46M	0.01%	-1.45M
Flagship pioneering	-	-	-1.36M
Capital research global investors	2.51M	0.01%	-1.21M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	5.12M	0.01%	5.12M	$84.52M
Artisan partners limited partnership	1.10M	0.03%	1.10M	$21.11M
Vanguard fiduciary trust	949.70K	0.00%	949.70K	$18.23M
Clearstead advisors	737.99K	0.13%	737.99K	$14.17M
Braidwell lp	296.32K	0.19%	296.32K	$5.69M

Sold Out

Holder	Change
Truvestments capital	-1.00
Toronto dominion bank	-2.00
Global financial private client	-5.00
Private wealth asset management	-8.00
Wealthtrak capital management	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	235	-7.11%	121,971,228	-19.30%	69	0.90%	136	-	47	-33.80%
Dec 31, 2025	69	-71.60%	34,419,053	-74.60%	19	0.32%	37	-70.63%	15	-76.92%
Sep 30, 2025	84	-62.83%	32,008,693	-75.36%	18	0.33%	39	-67.77%	28	-56.25%
Jun 30, 2025	230	4.07%	137,233,427	3.48%	80	1.33%	122	14.02%	66	-17.50%
Mar 31, 2025	220	-3.51%	132,840,276	3.83%	77	1.36%	108	-14.96%	80	35.59%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Scottish Mortgage Ord	7.04M	4.44%	-
Vanguard Health Care Inv	4.40M	3.03%	-5.17M
Vanguard Total Stock Mkt Idx Inv	4.26M	2.69%	16.57K
Vanguard US Total Market Shares ETF	3.33M	2.29%	-161.11K
iShares Russell 2000 ETF	3.34M	2.10%	28.11K
State Street® SPDR® S&P® Biotech ETF	3.16M	1.99%	-31.23K
Vanguard Small Cap Index	3.11M	1.96%	-4.20K
Vanguard US Growth Investor	3.04M	1.91%	-
Baillie Gifford US Equity Growth	3.04M	1.91%	-
T. Rowe Price Health Sciences	2.22M	1.52%	-278.46K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 06, 2026	Watts Ryan J.	President and CEO	Sell	$580.77K
Jan 06, 2026	Schuth Alexander O.	COFO and Secretary	Sell	$284.10K
Dec 11, 2025	BAKER BROS. ADVISORS LP	-	Buy	$1.91K
Dec 11, 2025	BAKER BROS. ADVISORS LP	-	Buy	$20.95K
Aug 12, 2025	Schuth Alexander O.	COFO and Secretary	Sell	$39.88K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	2
2025 Q4	2	-
2025 Q3	-	4
2025 Q2	-	-
2025 Q1	-	8

DNLI Ownership FAQ

Who Owns Denali Therapeutics?

Denali Therapeutics shareholders are primarily institutional investors at 69.52%, followed by 9.13% insiders and 21.35% retail investors. The average institutional ownership in Denali Therapeutics's industry, Biotech Stocks , is 35.75%, which Denali Therapeutics exceeds.

Who owns the most shares of Denali Therapeutics?

Denali Therapeutics’s largest shareholders are Blackrock (13.17M shares, 8.82%), Vanguard group (13.06M shares, 7.57%), and Blackrock funding, inc. /de (13.03M shares, 7.43%). Together, they hold 23.82% of Denali Therapeutics’s total shares outstanding.

Does Blackrock own Denali Therapeutics?

Yes, BlackRock owns 8.82% of Denali Therapeutics, totaling 13.17M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 305.91M$. In the last quarter, BlackRock increased its holdings by 974.71K shares, a 7.99% change.

Who is Denali Therapeutics’s biggest shareholder by percentage of total assets invested?

Crestline management, lp is Denali Therapeutics’s biggest shareholder by percentage of total assets invested, with 91.74% of its assets in 2.21M Denali Therapeutics shares, valued at 42.45M$.

Who is the top mutual fund holder of Denali Therapeutics shares?

Scottish Mortgage Ord is the top mutual fund holder of Denali Therapeutics shares, with 4.44% of its total shares outstanding invested in 7.04M Denali Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools